- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
216 Cards in this Set
- Front
- Back
|
Why Local Anesthesia and Medical
Emergencies in the Same Course?? |
• Stress is the most common cause of a
medical emergency • Injections cause stress • Injections cause medical emergencies |
|
Stress and Emergency
|
• Stress predisposes anyone to a medical
emergency • Administration of local anesthesia is the most stressful procedure performed in the dental office • > 50% of medical emergencies in a dental clinic occur during administration of local anesthesia |
|
What is the Best Way to Take
Care of a Medical Emergency? |
Prevention!
Prevention!! Prevention!!! |
|
What is the most important
thing you can do to Prevent Medical Emergencies? |
Know Your Patient!!!
Know Your Patient!!! Know Your Patient!!! |
|
How do you get to
know your patient? |
Physical Evaluation
• Medical History Questionnaire • Vital Signs • Visual Inspection • Additional (focused) evaluation Medical History Questionnaire • Review UNC SOD Health History Questionnaire • Ask delving questions about any positive response. • I always ask: “are you taking any medications?” “are you allergic to anything?” “are you under a physicians care for anything?” Vital Signs • Blood Pressure • Heart Rate and Rhythm • Respiratory Rate • Temperature • Height • Weight |
|
Technique for Measuring
Blood Pressure |
• Patient seated, upright
• Patient’s arm relaxed, slightly flexed, supported on a firm surface, at the level of the heart • Patient should relax in chair at least 5 minutes before BP is recorded • Proper cuff size • Cuff properly positioned • If measuring manually – Stethoscope positioned properly – Lower margin of cuff 1” above antecubital fossa – Release pressure gradually (2-3mm Hg/second) – Pulse first heard, then muffled, then disappears |
|
Technique for Measuring
Pulse Rate |
Machine
• Manually – Radial – Brachial (infant) – Carotid – Femoral |
|
Other Vital Signs
|
Respiratory Rate
– Surreptitiously – 30-60 sec • Temperature – Digital, tempa-dot, skin, ear – Usually not done unless you suspect fever or infection • Height and Weight – Okay to ask patient – Measure if patient is obviously wrong – Measure if patient will be sedated or given a lot of drugs |
|
Visual Inspection
|
• General appearance
• Level of apprehension • Posture, body movements, speech • Nondental odors on breath – Diabetes, uremia, alcohol • Skin – Diabetes, hyperthyroid, apprehensive – Pallor, cyanosis, flushed, jaundiced • JVD, Clubbing, Swollen ankles, Exopthalmos |
|
Additional (Focused) Evaluation
|
• Ask more questions about each of the
medical conditions identified in the Medical History Questionnaire (sometimes you can learn a lot of medicine from a well informed patient) • Ask more questions about each of the medical conditions you suspect from your physical exam |
|
Additional tests?
|
– Listen to heart and lungs
– ECG – PFTs – CBC, Chem 7 – UA – CXR |
|
Anxiety Recognition
|
• Heightened anxiety and fear of
dentistry • Can lead to the acute exacerbation of medical problems – Angina, seizures, asthma • Can lead to stress related problems – Hyperventilation, vasodepressor syncope • Medical history questionnaire – Do you have fainting spells or seizures – Have you had any serious trouble associated with any previous dental treatment • Anxiety questionnaire • Art of observation |
|
Art of Observation
|
• In Reception Area
– Questions receptionist regarding injections, sedation – Nervous conversations with other patients in area – Hx of emergency dental care only – Hx of canceled appointments for nonemergency tx – Cold, sweaty palms • In Dental Chair – Unnaturally stiff posture – Nervous play with tissue or handkerchief – White-knuckle syndrome – Perspiration on forehead and hands – Over willingness to cooperate with doctor – Quick answers – BP, P, trembling, sweat, dilated pupils |
|
Determination of Medical Risk
|
• Can pt physically and psychologically
tolerate stress of treatment in relative safety? • Is pt at a greater risk of morbidity or mortality than normal during treatment? • If pt is a greater risk, what treatment modification should be used to minimize the risk during the treatment? • Is the risk too great for the patient to be managed safely in the dental office? |
|
ASA Grades
|
Valuable to determination risk before dental procedures
ASA I: normal healthy pt without systemic ds ASA II: pt with mild systemic ds ASA III: pt with severe systemic ds that limits activity but is not incapacitating ASA IV: pt with an incapacitating systemic ds that is a constant threat to life ASA V: a moribund pt not expected to survive 24 hrs with or without an operation ASA E: emergency operation, any variety (e.g.. ASA E-III) |
|
Medical Consultation
|
• Complete the pt’s dental and physical
evaluation • Be prepared to discuss fully with the pt’s physician the proposed dental tx • Very important to determine the pt’s ability to tolerate in relative safety the stress involved in proposed dental tx • Telephone - if in a hurry – Receptionist: your name and pt’s name – Physician: • Summarize your evaluation, dx, and proposed plan of treatment • Ask for additional information and suggestions • Discuss any problems – Write a complete report of phoncon in record – F/U with written letter |
|
Why Reduce Stress?
|
• Stress
– Physiologic: pain, strenuous exercise – Psychologic: anxiety, fear • Adrenal medulla epi, norepi • Epi, norepi cardiovascular workload • Cardiovascular work angina, dysrythmia, MI • Lungs bronchospasm, pulmonary edema • CNS stroke, seizure |
|
Stress Reduction Protocol
|
• Premedication?
• Appointment scheduling – Tolerate stress best when well rested – Usually morning • Minimize waiting time in reception area • Record VS – Both preop and postop – Compare to VS from earlier visit |
|
Unc vs. syncope
|
• Unconsciousness - a lack of response to sensory
stimulation • Syncope – sudden, transient (<30 minutes) LOC • Regardless of the cause management remains the same • Position • Airway • Breathing • Circulation • Definitive Care |
|
Differential Diagnosis of Syncope
|
• 30+ causes
• Neurogenic, Vascular, Endocrinopathies, Toxins/Drugs, Psychogenic, Cardiogenic, Disorders of Oxygenation • For you, the emergency treatment is more important than the diagnosis |
|
Unconsciousness
Predisposing Factors |
• Stress
• Primary cause in dental setting • Impaired physical status • ASA III or IV • Administration or ingestion of drugs • Analgesics • Antianxiety agents |
|
Syncope -
Predisposing Factor Local Anesthesia |
• Most commonly used drug in dentistry
• >1 million carpules/day in USA • Major predisposing role in syncope • Overwhelming majority stress induced • Rarely overdose or allergy |
|
Possible Causes of Unconsciousness
in the Dental Office |
• Vasodepressor syncope Most common
• Drug administration/ingestion Common • Orthostatic hypotension Less common • Epilepsy Less common • Hypoglycemic reax Less common • Acute adrenal insufficiency Rare • Acute allergic reax Rare • Acute MI Rare • CVA Rare • Hyperglycemic reax Rare • Hyperventilation Rare |
|
Prevention of Unconsciousness
|
• Thorough pretreatment medical and dental
examination • Medical disabilities • Psychological disabilities • Stress reduction protocol • Patient in supine (or feet 10°) position • Prevents cerebral anoxia |
|
Pathophysiology of Unconsciousness
|
• Inadequate delivery of blood/O2 to the brain
• Acute adrenal insufficiency; Hypotension • Orthostatic hypotension; Vasodepressor syncope • Systemic or local metabolic deficiencies • Acute allergic reax; Drug ingestion/administration • [glu]; [glu]; Hyperventilation • Direct or reflex effects on the nervous system • CVA; Convulsive episode • Psychic mechanisms • Hyperventilation; Vasodepressor syncope |
|
Inadequate Cerebral Circulation
|
• Dilation of the peripheral arterioles
• Failure of normal peripheral vasoconstrictor activity (orthostatic hypotension) • A sharp drop in cardiac output (from heart ds, dysrhythmias, or decreased blood volume) • Constriction of cerebral vessels as CO2 is lost through hyperventilation • Occlusion or narrowing of the internal carotid or other arteries to the brain • Life threatening ventricular dysrhythmias |
|
Brain Metabolism
|
• Oxidation of glucose provides most energy
• 2% of body mass • Uses 20% of O2 consumed by body • Uses 65% of Glucose consumed by body • Requires continuous supply of both glucose and O2 • Anoxia • Unconscious <10 seconds • Permanent brain damage 4-6 minutes • Cardiac arrest 5-10 minutes |
|
Vasodepressor Syncope
|
• AKA vasovagal syncope or common faint
• Frequently observed • >50% of all medical emergencies in dental office • Usually benign and self-limiting • 25,000 faints, all recovered • Potentially life threatening • Airway obstruction • Injury from fall |
|
Vasodepressor Syncope
Predisposing Psychogenic Factors |
• Psychogenic factors
• Fright • Anxiety • Emotional stress • Receipt of unwelcome news • Pain, especially sudden and unexpected pain • Sight of blood or surgical instruments (e.g.. Local anesthetic syringe) |
|
Vasodepressor Syncope
Predisposing nonpsychogenic Factors |
Nonpsychogenic factors
• Upright or standing posture • Hunger • Exhaustion • Poor physical condition • Hot, humid, crowded environment • Male gender • Age 16 - 35 |
|
Vasodepressor Syncope
Clinical Manifestations |
• Signs and symptoms usually develop rapidly
• Actual LOC does not occur immediately • Presyncope • Syncope • Postsyncope (Recovery) |
|
Early
Presyncope |
• Early
• Feeling of warmth • Pale or ashen-gray skin • Heavy perspiration • C/O “feeling bad” or “feeling faint” • Nausea • BP at baseline or lower • tachycardia |
|
Late presyncope
|
• Late
• Pupillary dilation • Yawning • Hyperpnea • Cold hands and feet • Hypotension • Bradycardia • Visual disturbances • Dizziness • LOC |
|
Syncope
|
• Breathing irregular, shallow, or apnea
• Pupils dilate • Deathlike appearance • Convulsive movements; muscular twitching • Bradycardia (<50 to asystole) • BP (30/15) • Pulse weak/thready • Muscle relaxation airway obstruction and/or incontinence • Usually lasts < 5 minutes |
|
Postsyncope
|
• Rapid recovery after proper positioning
• May exhibit (minutes to hours) • Pallor • Nausea • Weakness • Sweating • Confusion or disorientation • Vital signs slowly return to normal • Tendency to faint again persists for many hours |
|
Vasodepressor Syncope
Pathophysiology |
• Stress leads to “fight or flight” response
• Epi and Norepi secreted • Changes tissue perfusion for increased muscular activity • If muscles are used blood flows back to heart thus maintaining BP and cerebral perfusion • If muscles not used (e.g.. sitting in a dental chair and “taking it like a man”) blood pools in peripheral vessels • Compensatory mechanisms activated but rapidly fatigue • Baroreceptors, Carotid sinus, Aortic sinus • Reflex bradycardia leads to CO decrease followed by BPdecrease • BP decrease + P decrease = cerebral perfusion decrease = LOC |
|
Vasodepressor Syncope
Management |
• Assess consciousness
• Activate office emergency system • Position patient supine with feet elevated 10° • A – B – C • Initiate Definitive Care • O2, VS, NH3, • Atropine if bradycardia persists • Postsyncopal Recovery • Postpone further dental treatment • Determine precipitating factors • Delayed Recovery • Activate EMS • Determine precipitating factors |
|
Orthostatic Hypotension
|
• AKA postural hypotension
• 2nd leading cause of transient LOC (syncope) in a dental setting • Not associated with fear or anxiety • Syncope occurs when patient assumes upright position • Failure of baroreceptor reflexes to mediate peripheral vascular resistance |
|
Orthostatic Hypotension
Predisposing Factors |
• Dehydration
• Drugs • Prolonged recumbancy • Age • Pregnancy • Varicose veins • Addison’s Ds (adrenocortical insufficiency) |
|
Orthostatic Hypotension
Prevention |
• Medical History questionnaire
• Medications • Hx of fainting, seizures • Physical Examination • Vital signs • Palpable pulse • Nail beds • Dental Therapy Considerations • Slowly reposition patient upright • Stand nearby as the patient stands after tx • Wheelchair to car after sedation |
|
Orthostatic Hypotension
Clinical Manifestations |
• Symptoms develop when pt stands
• Standing Pincreases >30 beats/minute • Standing systolic BP drops >25 mm Hg • Standing diastolic BP drops >10 mm Hg • LOC |
|
Orthostatic Hypotension
Pathophysiology |
• Normal reactions to change from supine
• Baroreceptors respond to arteriolar constriction and P increases • Reflex venous constriction • Muscle tone and contraction increases (legs, abdomen) • Respiration increases - aids return of blood to right heart • Neurohormonal secretions increases (ADH, renin, etc) • Failure of any of the above • Rapid BP drop + No change in P = Orthostatic Hypotension |
|
Orthostatic Hypotension
Management |
• Assess consciousness
• Activate office emergency system • Position: supine, feet up 10 • A – B – C • Definitive care • O2, VS • Slowly reposition chair, discharge pt • Summon EMS if episode continues |
|
Acute Adrenal Insufficiency
|
• AKA – adrenal crisis
• 1° - Addison’s Ds • 2° - Atrophy of adrenal cortex • Adrenal cortex – cortisol helps manage stress • Uncommon • Potentially life threatening • Readily treatable • Hypersecretion is Cushing’s Ds |
|
Adrenal Insufficiency
Predisposing Factors |
• Addison’s Ds
• Sudden withdrawal of steroids after prolonged exogenous administration • Stress – physiologic or psychologic • Bilateral adrenalectomy • Sudden destruction of pituitary gland • Injury to both adrenal glands |
|
Adrenal Insufficiency
Prevention |
• Medical hx questionnaire and dialogue
• Rule of twos • 20mg of exogenous cortisol (or equivalent) • 2 weeks or longer • Within the last two years |
|
Adrenal Insufficiency
Clinical Manifestations |
• Lethargy, extreme fatigue, weakness
• Anorexia, weight loss • Hyperpigmentation (palms, soles, elbows, knees, buccal mucosa, old scars) • Hypotension (110/70) • Nausea, vomiting • In dental setting • Progressive mental confusion • Pain in abdomen/back/legs • Cardiovascular deterioration • Coma • Mortality usually secondary to hypotension or hypoglycemia |
|
Adrenal Insufficiency
Pathophysiology |
• Addison’s Ds (primary) patients have destruction of
the adrenal cortex • Clinical manifestations usually do not develop until 90% of the cortex is gone • Require lifelong exogenous cortisol • Unable to respond to ACTH • Secondary adrenal insufficiency patients receive exogenous steroids for multiple medical therapies • Exogenous steroids cause feedback inhibition of the pituitary (ACTH) and adrenal gland atrophy |
|
Adrenal Insufficiency
Management |
• Remember rule of twos
• Prevent acute problems by providing supplemental steroid replacement of at least double the daily dose of their normal regimen. • Remember to taper afterwards |
|
Airway Obstruction
|
• A sudden, complete or partial loss of airway patency
that interferes with respiration • Acute emergency – brain cell death in 4-5 minutes • Dental profession lends itself to foreign objects being lodged in the upper airway |
|
Airway Obstruction
Pathophysiology |
• Self evident
• Usually aspiration into the right mainstem bronchus • May lodge in the larynx (narrowest) and cause complete obstruction • Respiratory arrest cardiac arrest cerebral ischemia death |
|
Airway Obstruction
Recognition |
• Universal choking sign
• Can’t speak, breath, cough • Panic • Cyanosis, costal and sternal retractions • Crowing noise in partial obstruction • In 3-4 minutes respiratory effort, BP, and heart rate drop; LOC • In 8-10 minutes full cardiac arrest |
|
Airway Obstruction
Prevention |
• Rubber dam
• Gauze throat screen • Attach floss to instruments that can be aspirated (e.g. rubber dam clamp) • Alert dental assistant • Good suction • Patient position • Magill forceps, Russian forceps |
|
Management of Airway Obstruction
|
When object falls back into the oropharynx and
airway is compromised • Tilt patient back into a head down position • Retrieve it if you can see it • Finger sweep (not in infants) • Encourage coughing • Back blows, manual thrusts • Heimlich maneuver • Head tilt, jaw thrust • Surgical airway (call EMS) • Surgical airway • Tracheostomy performed in OR or ED • Cricothyrotomy is fastest way into the airway • Contraindicated in children • Puncture through the cricothyroid membrane to restore ventilation • When object disappears into oropharynx and airway is not compromised • Immediately send patient for CXR and KUB • Appropriate medical consults • F/U radiographs in 2-3 days to insure the object has passed completely through GI tract |
|
Hyperventilation
|
• Ventilation in excess of what is required to maintain
normal PaO2 and PaCO2 • Produced by an increase in frequency and/or depth of respiration • AKA Vapors, effort syndrome, soldier’s heart • Commonly as a result of extreme anxiety in the dental office |
|
Hyperventilation
Pathophysiology |
• Anxiety (fight or flight)
• Respiratory alkalosis (decrease in CO2) • increased catecholamines (chest tightness) • decreased ionized calcium = neuromuscular irritability |
|
Hyperventilation
Predisposing Factors |
• Anxiety prone
• Fear of dental therapy |
|
Hyperventilation
Signs and Symptoms |
• Unaware of hyperventilation
• Complaints of chest tightness, lightheadedness, palpitations, tingling or paresthesia of the extremities or peri-oral areas • Muscular twitching • Syncope |
|
Hyperventilation
Management |
• Reduce anxiety
• Stop procedure, sit patient upright, control breathing • Cup hands on face to rebreathe air (increase CO2) • Do not give O2 (may worsen condition) • Administer benzodiazepines if necessary (rarely required) |
|
Hyperventilation
Prevention |
• Talk to your patients about their fears of dental tx
• Reduce anxiety and stress • Check VS before starting dental tx |
|
Asthma
basics |
• Reactive airway ds
• Constriction of the distal airway in response to atopic challenge • Most chronic ds of childhood • Almost 10% of children have the ds and the incidence is rising |
|
Asthma
Pathophysiology |
• In most cases a type 1 immune reaction which is IgE
mediated (extrinsic) • Causes mast cell degranulation with release of inflammatory mediators and subsequent bronchoconstriction • Intrinsic asthma usually in adults caused by environmental pollution, respiratory infection • Status Asthmaticus / bronchospasm |
|
Asthma
Predisposing Factors |
• History of the disease
• Stress • Psychological factors • Drug reaction ( PCN) |
|
Asthma
Signs and Symptoms |
• May occur gradually or rapidly
• Thickness in chest followed by coughing • Sputum production with wheezing and muscle retraction • Air hunger and apprehension/anxiety rise • BP and P rise, dyspnea increases • Termination heralded by intense coughing and expectoration of mucous plug followed by relief |
|
Asthma
Management |
• Stop procedure, sit pt upright with arms forward
• Reduce anxiety, remove kids from tx room • Administer patient’s bronchodilator • Administer B2 agonist drugs (epinephrine, isoproterenol, albuterol) by inhalation • In severe attack: O2, epi injection IM/SC (0.3mg), EMS |
|
Asthma
Prevention |
• Good medical hx and dialogue
• Reduce anxiety • Sedation • Nitrous Oxide is safe in asthmatic patient, does not irritate the respiratory mucosa |
|
Pulmonary Edema
|
• Most common cause of acute pulmonary edema is
congestive heart failure • Left ventricular failure leads to right ventricular failure and CHF • Pulmonary edema is marked by an excess of serous fluid in the alveolar/interstitial spaces of the lungs which causes extreme difficulty in breathing |
|
Pulmonary Edema
Pathophysiology |
• An increase in afterload (e.g. HTN) causes
hypertrophy, progresses to dilation as failure continues • Dyspnea on exercise, hypervolemia secondary to decreased GFR and sodium retention • Hypervolemia increases capillary hydrostatic pressure and edema of the extremities starts • In the supine position fluid is forced centrally causing increased atrial pressures which increases pulmonary pressure and fluid escapes into the alveoli |
|
Pulmonary Edema
Predisposing Factors |
• Physical stress
• Psychological stress • Salty meals • Noncompliance with medications • Infection • Orthopnea is positional dyspnea |
|
Pulmonary Edema
Signs and Symptoms |
• Onset is acute
• Dyspnea and orthopnea present • Feeling of suffocation and anxiety • Chest pressure, tachypnea, cough • Cyanosis, frothy bloody saliva, panic • Respiratory arrest, cardiac arrest, death |
|
Pulmonary Edema
Management |
• Stop procedure
• Position patient upright, EMS • Reduce anxiety, monitor airway • Bloody, bloodless phlebotomy with 3 tourniquets • Use vasodilator (e.g. NTG) to reduce preload |
|
Diabetes Mellitus
basics |
• Inappropriate hypergylcemia from absolute
deficiency or reduced effectiveness of insulin • Approximately 6% of U.S. population • Incidence is increasing • Disease process is primarily microangiopathic with end organ damage • Type 1 and Type 2 |
|
Diabetes Mellitus
1. Pathophysiology (hypergylcemia) |
-after eating meal blood glucose rises
-blood glucose remains elevated in the diabetic -glucose appears in urine after 180mg/dl (glycosuria) -through osmosis, loss of water and electrolytes -dehydration ensues (polyuria,polydipsia) -weight loss as a result of water loss and skeletal muscle breakdown -elevated glucose is unusable and free fatty acids are broken down to ketones for fuel (ketoacidosis – fruity smell on breath) -as ketogenesis continues, metabolic acidosis ensues (cardiac depression) -metabolic acidosis causes compensatory respiratory alkalosis (Kussmaul’s breathing – slow deep breaths) -hypergylcemic coma ensues (time =48hrs) |
|
Diabetes Mellitus
1. Pathophysiology (Hypogylcemia) |
-most common acute complication
-blood glucose below 50mg/dl in adults (40mg/dl) in children -as blood glucose drops this alters normal functioning of the cerebral cortex -increased epinephrine secretion causes elevated blood pressures, sweating, tachycardia -hypoglycemic coma |
|
Diabetes Mellitus
2. Predisposing Factors |
-genetic disorder
-iatrogenic causes (surgery,cancer,etc.) |
|
Diabetes Mellitus
3. Signs and Symptoms (Hyperglycemia) |
-generally diagnosed by FBG
-florid appearance, hot and dry skin (dehydration) -polydipsia, polyuria, polyphagia -Kussmaul’s respirations -fruity odor to breath (ketoacidosis) -tachycardia, hypotension, coma |
|
Diabetes Mellitus
3. Signs and Symptoms (Hypoglycemia) |
-much more common
-diminished cerebral function, lethargy -hunger, nausea -sweating, tachycardia, piloerection, anxiety -cold, wet skin -loss of consciousness and seizure activity -irreversible cerebral damage |
|
Diabetes Mellitus
4. Management (Hyperglycemia) |
-stop procedure
-supine position with legs elevated -support airway, breathing -EMS -start IV NS (D5W if not sure), O2 -do not give insulin! |
|
Diabetes Mellitus
4. Management (Hypoglycemia) |
-stop procedure
-sit upright (or whatever makes pt comfortable) -support airway, breathing -administer oral carbohydrates -if loss of consciousness, notify EMS and start IV/IM glucagon or 50% dextrose |
|
Diabetes Mellitus
5. Prevention |
-No modifications usually necessary with Type 2
-Advise Type 1 patients to eat normal meals and use insulin as prescribed for minor procedure -Consult physician for procedures that impair inability to eat post-operatively to modify the insulin regimen (e.g. full mouth extraction, denture related procedures) -Antibiotics |
|
Thyroid Disease
|
• Produces and secretes three essential hormones for
regulation of biochemical activity • Thyroxin (T4), Triiodothyroxine (T3), calcitonin • Hypothyroid/hyperthyroid/euthyroid • Hypothyroidism – deficient state of thyroid hormones (cretinism in children, myxedema as an adult) Myxedema coma mortality 50% • Hyperthyroidism – excess state of thyroid hormones (thyrotoxicosis, Grave’s disease) Thyroid storm is life- threatening, high mortality |
|
Thyroid Disease
1. Pathophysiology (Hypothyroidism) |
-in effect body functions and metabolism slow
down -mucopolysaccarides and mucoproteins infiltrate the skin leading to puffy non-pitting edema (myxedema) -cardiac enlargement, leads to effusions, cardiac and pulmonary failure -coma is the end point secondary to hypothermia, hypoglycemia, CO2 retention, hypotension, hypoxia |
|
Thyroid Disease
1. Pathophysiology (Hyperthyroidism) |
-elevation of body basal metabolic rate and
increased energy consumption -increased heart rate and cardiac irritability -liver dysfunction is also present, jaundice may appear, use medications cautiously -thyroid storm characterized by hyperpyrexia (> 105 degrees F), dysrythmia, CHF, pulmonary edema |
|
Thyroid Disease
2. Predisposing Factors |
a. Hypothyroidism- usually as a result of idiopathic
atrophy (autoimmune?), more common in females, careful with CNS depressants (e.g. sedation) b. Hyperthyroidism- Grave’s disease most common, antibodies against fractions of the gland (autoimmune), more common in females, progression to storm is rare |
|
Thyroid Disease
3. Signs and Symptoms (Hypothyroidism) |
-in children (cretinism) retarded physical and
mental development, flat nose, broad puffy face, enlarged tongue -in adult, cold intolerance, weight gain, fatigue, non-pitting edema, hoarse voice, bradycardia -myxedema coma: hypothermia, bradycardia, hypotension, loss of consciousness |
|
Thyroid Disease
3. Signs and Symptoms (Hyperthyroidism) |
-nervousness, irritability, insomnia
-intolerance to heat, tremors, sweating, weight loss with increased appetite, exopthalmos, staring (Grave’s) -increased blood pressure and tachycardia -thyroid storm severe hypermetabolism with hyperpyrexia (agitation, psychotic behavior) |
|
Thyroid Disease
4. Management (Hypothyroidism) |
-stop procedure
-position supine -support airway/breathing -EMS -start IV with D5W -hospitalization for management |
|
Thyroid Disease
4. Management (Hyperthyroidism) |
-stop procedure
-position supine -support airway/breathing -EMS -start IV D5W -hospitalization for management |
|
Thyroid Disease
5. Prevention |
-euthyroid patients do not require modification
-hypothyroidism consult physician, careful with CNS depressants -hyperthyroidism consult physician, do not use atropine (vagolytic), watch epinephrine dosage, do not use gingival retraction cords that have been treated with racemic epinephrine |
|
Cerebrovascular Accident
|
• AKA “stroke”
• Third leading cause of death • Most common form of brain disease • Two major types hemorrhagic and occlusive • Incidence is decreasing, but mortality is increasing • Rare in children but can occur |
|
Cerebrovascular Accident
1. Pathophysiology (Infarction) |
-cannot store O2 or glucose
-an occlusive event disrupts blood flow -ischemia causes lactate to form which alters vascular permeability and edema forms -edema (causes headache) may force cerebral hemispheres inferiorly and cause herniation into the brain stem -may cause ischemia and infarction of medulla (brain stem and leads to death) |
|
Cerebrovascular Accident
1. Pathophysiology ( Hemorrhagic) |
-rapid, more intense, higher mortality
-two pathways, aneurysms (dilated vessels) and weakened vessel walls (HTN), both rupture -once rupture occurs blood fills the cranium and causes a mass effect and can cause herniation into brain stem -edema also develops and makes bad situation worse |
|
Cerebrovascular Accident
2. Predisposing Factors |
-HTN is the single most important risk factor
(Framingham) -other factors include diabetes, cardiac disease, hypercholesteremia -dental office good model for elevated blood pressure |
|
Cerebrovascular Disease
3. Signs and Symptoms |
-In TIA onset is abrupt and recovery rapid,
paresthesias and monocular blindness are hallmarks -In Infarction gradual onset, usually preceded by TIA, mild headache, neurologic deficits -In Hemorrhage, abrupt onset, violent headache with vomiting, confusion, coma, and death (50% lose consciousness 50% mortality) |
|
Cerebrovascular Disease
Management |
-stop procedure
-position with head and chest up (decrease intracranial blood flow and pressure) -support airway/breathing -notify EMS -Start IV D5W, hospitalization |
|
Cerebrovascular Disease
5. Prevention |
-management of hypertension
-post CVA patients should not have elective dental therapy for 6 months -watch for blood thinners -judicious epinephrine use (retraction cord) -dialogue with physician |
|
Seizures
|
• Transient alteration in brain function
characterized by abrupt onset of motor, sensory and psychic symptoms • Not usually a life threatening event except in status epilepticus • Have many underlying causes • Prevention of injury to patient and supportive therapy are essential |
|
Seizures
1. Pathophysiology |
-epilepsy is not a disease but a symptom of brain
dysfunction -increased neuronal permeability of Na+ and K+ -these hyperexcitable neurons have recurrent, high frequency episodes of activity -the action potential is propagated along neural pathways and neighboring neurons are stimulated to discharge (recruitment) -the action potential then travels to the subcortical areas or the thalamus and if the discharge remains localized a partial seizure develops, if it spreads additional neurons are recruited and it becomes generalized -increased cerebral blood flow and O2 use |
|
Seizures
2. Types of Seizures |
a. Partial – involve specific area of brain, may have
illusions, hallucinations, motor activity, conscious level is disturbed, amnesia b. Grand Mal – AKA generalized tonic clonic seizure - most common form of epilepsy -lasts 2-3 minutes, post-ictal phase 5-15mins, complete recovery several hours c. Psychomotor – AKA temporal lobe epilepsy essentially a partial seizure -automatisms, apparently purposeful movement (e.g. lip smacking) d. Status epilepticus – unbreaking seizure -in convulsive form 10% mortality -most common precipitating factor is non compliance with medication e. Petit Mal – AKA absence seizure -most common in children, usually progresses to grand mal -lasts up to 30 seconds, no movement -multiple daily episodes f. Jacksonian Seizure – A partial marching seizure -loss of consciousness after midline crossed |
|
Seizures
3. Predisposing Factors |
- generalized metabolic/toxic disturbance
which increases neuronal excitation -Cerebrovascular insufficiency -triggers: sleep, menstrual cycle, fatigue, flickering lights, stress |
|
Seizures
4. Signs and Symptoms |
a. Partial – simple when consciousness is
unaltered, complex when it is altered -aura (bad taste) followed by automatisms -mild confusion amnesia b. Petit Mal – sudden immobility and blank stare, blinking and amnesia (lost time) c. Grand Mal – prodromal phase of changes in emotion reactivity (depression/anxiety) -aura heralds seizure (taste, hallucination, visual disturbance) -loss of consciousness, falls (injury), jerking movements, increase in blood pressure and heart rate -tonic/clonic activity -in post ictal phase consciousness returns, muscular flaccidity (bowel/bladder), amnesia, confusion |
|
Seizures
5. Management |
-stop procedure remove dental appliances
-position supine/floor -EMS -support airway/breathing -soft suction as appropriate -remove equipment/instruments -pad head -hold feet/hands -reassure patient and monitor vitals -IV/IM benzodiazepines in status (10mg valium) |
|
Seizures
6. Prevention |
-caring and discussing fears (embarrassment,
social rejection, higher rate of suicide) -anxiety reduction -sedation (nitrous) or oral (benzodiazepines) |
|
Drug Overdose
|
• Signs and symptoms that result from overly
high drug concentration in the blood and tissue • In dentistry most commonly from local anesthesia and epinephrine (also opioids and sedatives) • Carefully separate out “allergy” to local anesthesia |
|
Drug Overdose
1. Pathophysiology (Cardiac) |
- in the cardiac system local anesthesia is used to
manage arrhythmias -in mild doses shortens action potential and refractory period -in moderate doses it decreases contractility, decreases cardiac output and blood pressure -in excessive doses causes massive peripheral vasodilatation, and cardiac depression with cardiac arrest |
|
Drug Overdose
1. Pathophysiology (CNS) |
-extremely sensitive readily crosses blood brain
barrier (Na+ channels) -possesses anticonvulsant property at mild dosages -paresthesias of peri-oral tissues and agitation in moderate doses from blockade of nerves -as drug levels increase seizures develop followed by CNS depression, respiratory arrest and cardiac arrest |
|
Drug Overdose
2. Predisposing Factors |
-age
-body weight (calculate) -liver disease -dose -route of administration -rate of injection -vascularity at injection site -use of vasoconstrictors (reduced toxicity) |
|
Drug Overdose
3. Signs and Symptoms |
-usually as a result of too large of a dose or rapid
intra-vascular injection -in minimal to moderate cases usually excitatory – confusion, slurred speech, tremor, nystagmus, blood pressure, heart rate and respiratory rate increase, tinnitus, numbness, drowsiness -in severe cases, seizures, loss of consciousness, respiratory depression, cardiac depression, death |
|
Drug Overdose
4. Management |
-stop procedure
-position comfortably/O2 -support airway/breathing -if seizure may give IV anticonvulsant (diazepam), same protocol for seizure -EMS, cardiac support if arrest |
|
Drug Overdose
5. Prevention |
-almost all cases of overdose preventable
-calculate drug dose -aspirate before injection -beware of patients with extensive liver disease -use the minimal dose necessary to adequately perform the procedure |
|
Drug Overdose
Epinephrine |
-less commonly from local anesthesia
preparations than from gingival retraction cord with racemic epinephrine -anxiety, elevated blood pressure, rate, palpitations, -may precipitate arrhythmia or myocardial infarction |
|
Allergy
|
• Hypersensitive state after exposure to an
allergen, re-exposure causes a heightened capacity to react • Type I (anaphylaxis), acute and life threatening • Type IV (delayed) local reaction through chronic exposure |
|
Allergy
1. Pathophysiology |
-sensitizing dose by initial exposure to allergen,
lymphocytes form IgE specific antibodies which attach to mast cell and basophils -challenge dose of allergen causes cross linking and degranulation of mast cells and basophils which release chemical mediators into the blood like histamine (major) which cause capillary permeability and vasodilatation = hypotension, bronchoconstriction is also caused -transudation of fluid and proteins causes laryngeal edema, angioedema, mucous secretion and dyspnea -decreased vasomotor tone and peripheral pooling of blood cause hypotension and shock |
|
Allergy
2. Predisposing Factors |
-antibiotics (penicillin)
-analgesics (aspirin) -antianxiety (barbiturates) -local anesthetics (esters, paraben preservative, sulfites) -acrylic (dentures) |
|
Allergy
3. Signs and Symptoms |
-the more intense the reaction, the more rapid the
onset of symptoms -angioneurotic edema from topical anesthesia - includes urticaria, erythema, swelling (may obstruct airway) -conjuctivitis, rhinitis, abdominal pain -wheezing, coughing, dyspnea, hoarseness -tachycardia, hypotension, cardiac arrest |
|
Allergy
4. Management |
-stop procedure
-position supine -support airway/breathing -EMS/O2 -Administer IM epi (0.3ml 1:1000) -Administer histamine blocker/steroid |
|
Allergy
5. Prevention |
-obtain good history
-physician consultation -formal allergy testing -modify drug regimens for cross reactivity -choose different route of administration |
|
Angina
|
• AKA ischemic heart disease
• Angina meaning suffocating pain or choking feeling • Indicates significant coronary artery disease • Indicates inadequate oxygen supply to the myocardium • Risk of adverse cardiac event greater |
|
Angina
1. Pathophysiology |
-transient inability of the coronary arteries to
provide adequate oxygenated blood to the myocardium -ischemic myocardium produces chemical mediators which act on the spinal cord to produce pain -the pain causes increased blood pressure and tachycardia which increase oxygen demand further (feedback loop) |
|
Angina
2. Predisposing Factors |
2. Predisposing Factors
-genetics, sex, age, race -smoking, HTN, diabetes, high cholesterol -stable (returns to baseline after activity stopped) -unstable (no activity required, spontaneous) |
|
Pharmacokinetics
1. Uptake |
-All local anesthetics vasodilate (procaine most
potent) with one exception (cocaine – binds to NE sites with resultant free NE) bupivicaine > lidocaine > mepivicaine -oral route ineffective due to hepatic first-pass and significant biotransformation to inactive metabolites -intratracheal uptake almost as fast as IV (emergencies) -IV use for ventricular dysrythmias |
|
Pharmacokinetics
2. Distribution |
-once absorbed in blood distributed to all
areas of the body especially vascular areas (brain, liver, spleen, kidneys etc.) -one half life of drug is the time to when there is a 50% drop in blood level bupivicaine > mepivicaine > lidocaine -all local anesthetics cross the blood brain barrier and the placental barrier |
|
Pharmacokinetics: 3. Metabolism (Esters)
|
-prototypical drug is procaine
-hydrolyzed in the plasma by pseudocholinesterase -rate of hydrolysis affects toxicity (longer hydrolysis phase increases toxicity -procaine is hydrolyzed to PABA prior to excretion in urine PABA causes allergic reactions -Atypical pseudocholinesterase deficiency is a hereditary condition in which there is impaired biotransformation of drugs like procaine and succinylcholine which leads to prolonged and toxic concentrations of the drugs (“difficulty” during general anesthesia) |
|
Pharmacokinetics
Metabolism (Amides) |
-prototypical drug is lidocaine
-biotransformation occurs primarily in the liver (hepatic disease) -prilocaine also metabolized partially in lungs -prilocaine and articaine can induce methemoglobinemia via metabolite orthotoluidine - lidocaine metabolites lead to sedative effect |
|
Pharmacokinetics
4. Excretion |
-primarily in the kidneys
-esters more secreted in metabolite form -amides more secreted in parent compound form -kidney disease may interfere with drug excretion and lead to toxicity |
|
Pharmacokinetics
5. Systemic Actions (CNS) |
-crosses blood brain barrier
-low drug levels anticonvulsant -high drug levels seizures “inhibition of inhibition” |
|
Objective Preconvulsive Signs and Symptoms
|
– Slurred speech
– Shivering – Muscular twitching – Tremor in muscles of face and distal extremities |
|
Subjective Preconvulsive Signs and Symptoms
|
• Subjective
– Bilateral perioral numbness – Warm, flushed feeling – Pleasant dreamlike state – Light-headedness – Dizziness – Inability to focus eyes – Tinnitus – Drowsiness – Disorientation |
|
Pharmacokinetics
5. Systemic Actions (Cardiovascular) |
-cardiac depression and vasodilation
-decreased cardiac output and hypotension -generalized vasodilation with the exception of cocaine |
|
Lidocaine Concentration in Blood
|
• After 2 carpules for intraoral local anesthesia:
0.5 – 2 micrograms/ml • Antidysrhythmic therapeutic levels: 1.8 – 6 micrograms/ml • Toxicity: > 6 micrograms/ml – Circulatory collapse • CO decrease, peripheral vasodilitation, BP decrease |
|
Pharmacokinetics
5. Systemic Actions (Miscellaneous) |
-neuromuscular blockade when combined with
general anesthesia -drug interactions potentially prolonging other CNS depressants -Malignant Hyperthermia (Hyperpyrexia to 108 degrees, muscle rigidity, hypotension, acidosis and death) Ca++ release in myoplasm. Can happen with amides not esters |
|
Vasoconstrictors
|
• Oppose the vasodilating property of local
anesthetics • Decrease perfusion to site of injection • Decrease absorption into the vascular system–lower blood levels decrease toxicity • Increase the duration of anesthesia • Decrease bleeding at the site of injection • For use in dentistry, they are all direct acting sympathomimetic amines • Act on alpha and beta adrenergic receptors to varying degrees • Alpha receptor activation causes vasoconstriction by acting on smooth muscle in vessel walls |
|
Vasoconstrictors dilutions
|
• The dilution is commonly referred to as a
ratio 1:1 = 1gram/1ml 1:1000 = 1g in 1000ml or 1mg/ml 1:10,000 = 0.1mg/ml 1:100,000 = 0.01mg/ml *In a 1.8cc (ml) solution of 1:100,000 you would have 0.018mg (18 micrograms) *1cc of 1% solution = 10mg of solute |
|
Epinephrine
|
-acts on both alpha and beta receptors; beta effects
predominate; AKA Adrenalin -large doses to a specific area leads to a high tissue concentration and the alpha effects take over -sodium bisulfite (anti-oxidation) used as preservative (shelf-life about 18 months); may cause allergy -BP increases, P increases, CO increases -max dose healthy 0.2mg (11 cartridges 1:100000) -max dose cardiac 0.04mg (2 cartridges 1:100000) |
|
Norepinephrine
|
-AKA Levophed, not routinely used or
recommended in dentistry -one fourth as potent as epinephrine -acts almost exclusively on alpha receptors -increases blood pressure, decreases heart rate and cardiac output -max dose healthy 0.34mg (10ml 1:30000) -max dose cardiac 0.14mg (4ml 1:30000) |
|
Levonordephrine
|
-AKA neo-cobefrin
-15% as potent as epinephrine -acts primarily on alpha receptors -less cardiac and CNS side effects -all patients max dose 1mg (20ml of a 1:20,000 – 11 cartridges) |
|
Vasoconstrictors
actually used |
• Only epinephrine and levonordephrine are available
in the US • With epinephrine there is a rebound vasodilation, as the alpha effect ceases beta receptors are stimulated • Use with caution in patients with significant cardiac disease, sulfite sensitivity, taking MAO inhibitors or tricyclic antidepressants or phenothiazines |
|
Duration of LA effect
affected by |
• Individual variation to drug
• Accuracy of administered drug • Status of tissue (vascularity, pH) • Anatomical variation • Type of injection administered (supraperiosteal vs. nerve block) |
|
Maximum Recommended Dose
|
• Manufacturer – see drug insert
• Malamed uses the more conservative dosage regimen suggested by the Council on Dental Therapeutics of the American Dental Association |
|
Procaine
|
• Ester AKA Novocain
• Used as the sole local anesthetic agent in US for many years; introduced in 1904 • Historically significant • Produces the most vasodilation • Used now to break ateriospasm • Now only used in combination in dentistry |
|
Procaine + Propoxycaine
|
• Combination of two esters
• Useful when amides absolutely contraindicated • Removed from the US in 1996 officially • Max dose is 6.6mg/kg |
|
Lidocaine
|
• AKA Xylocaine
• Amide introduced in 1948 - “gold standard” • Onset 2-3 mins T1/2 1.6hrs • May be used as topical in 5% concentration • Lidocaine without epi is not clinically useful pulpal anesthesia 5-10 mins • 2% lidocaine with epi 1:50,000 is used for hemostasis • 2% lidocaine with epi 1:100,000 is the most common |
|
Lidocaine
• 2% lidocaine plain |
-pulpal anesthesia 5-10mins soft tissue 60-
120mins -max dose 4.4mg/kg absolute max 300mg |
|
• 2% lidocaine with epi 1:50000
|
-pulpal anesthesia 60mins soft tissue 3-5hrs
-max dose 6.6mg/kg absolute max 500mg |
|
Lidocaine
• 2% lidocaine with epi 1:100,000 |
-this is what you will use most
-pulpal anesthesia 60mins, soft tissue 3-5hrs -max dose 6.6mg/kg, absolute max 500mg -cartridge is 1.8cc = 36mg of lidocaine and 0.018mg of epi in one cartridge |
|
Mepivicaine
|
• Amide, AKA Polocaine/Carbocaine
• Onset 1-2mins T1/2 1.9hrs • 3% mepivicaine plain is useful for patients who are unable to receive a vasoconstrictor -pulpal anesthesia 20-40mins soft tissue 2-3hrs max dose 6.6mg/kg; absolute 400mg • 2% mepivicaine with levonordefrin 1:20,000 -pulpal anesthesia 60min; soft tissue 3-5hrs -max dose 6.6mg/kg; absolute max 400mg -not as good for hemostasis |
|
Prilocaine
|
• Amide, AKA Citanest
• Onset 2-4mins T1/2 1.6hrs • May cause methemoglobin formation • 4% prilocaine plain -pulpal anesthesia 40-60mins soft tissue 2-4hrs -max dose 6.0mg/kg absolute max 400mg |
|
Prilocaine
|
• Citanest Forte
• 4% prilocaine with epi 1:200,000 -pulpal anesthesia 60-90mins soft tissue 3- 8hrs -max dose 6.0mg/kg absolute max 400mg |
|
Articaine
|
|
|
Bupivicaine
|
• Amide, AKA Marcaine
• Used for lengthy or painful procedures • Onset 6-10mins T1/2 2.7hrs • 0.5% bupivicaine with epi 1:200,000 -pulpal anesthesia 90-180mins soft tissue 4-9hrs -max dose 1.3mg/kg, absolute max 90mg |
|
Etidocaine
|
• Amide, AKA Duranest
• Lengthy, painful procedures • Onset 2-3mins T1/2 2.6hrs • 1.5% etidocaine with epi 1:200,000 -pulpal anesthesia 90-180mins soft tissue 4- 9hrs -max dose 8mg/kg absolute max dose 400mg |
|
Brief Summary of LA agents
|
• Lidocaine – standard
• Mepivicaine – heart patients • Prilocaine – alternative • Articaine – alternative • Bupivicaine – long acting • Etidocaine – long acting |
|
Topical Anesthesia
|
• Penetrates the mucous membrane 2-3mm
• Provides relief of pain from needle penetration • Usually in higher concentration than injectable local anesthesia • Many names/brands benzocaine (hurricaine), butacaine, cocaine (not desirable), Dyclonine (is a ketone and useful in allergic patients), lidocaine, tetracaine (cetacaine) |
|
Local Anesthesia Pearls
|
• Use atraumatic injection technique
• Use topical anesthesia • How long do you need the patient anesthetized? • Use the minimal amount of drug required to allow you and the patient to complete the procedure comfortably • Think about post-operative pain and use a longer lasting drug to achieve better pain control • Be concerned about self-mutilation/burns in your patients • If you need hemostasis choose the appropriate anesthetic • Be mindful of the medical status of your patients |
|
Needle
Gauges |
• 25 gauge RED
• 27 gauge YELLOW • 30 gauge BLUE |
|
Needle Lengths
|
• Short 20mm
• Long 32mm |
|
Loading aspirating syringe
|
Place Needle on Syringe
Pull Back on Thumb Ring to Insert Carpule into Syringe Slowly slide carpule forward to penetrate diaphragm Put in needle puncture guard Engage harpoon into stopper Resheath needle after injection |
|
Atraumatic Injection Technique
|
1. Use a sterilized sharp needle
2. Check the flow of local anesthetic solution 3. Solution at room temperature 4. Position the patient – supine if tolerated 5. Dry the tissue 6. Apply topical antiseptic (optional) 7. Apply topical anesthetic 8. Communicate with the patient – explain superficial numbness, minimize discomfort 9. Establish a firm hand rest 10. Make the tissue taut 11. Keep the syringe out of patient’s sight 12. Insert the needle into the mucosa – bevel towards bone 13. Watch and communicate with the patient – never say that it won’t hurt 14. Inject several drops (optional) 15. Slowly advance needle towards target 16. Aspirate 17. Slowly deposit the local anesthetic solution 18. Communicate with the patient – explain why you are injecting slowly 19. Slowly withdraw the syringe and cap the needle using safe technique 20. Observe the patient after the injection 21. Record the injection in the patient’s chart |
|
Maxillary
Nerves that can be blocked |
1. Posterior Superior Alveolar
(PSA) 2. Infraorbital 3. Maxillary (2nd Division Block) 5. Greater Palatine 6. Nasopalatine |
|
Adv of blocks
|
Advantages
• Fewer injections (pain) when anesthetizing several sites • Less total volume of anesthetic solution and less chance of overdose • Lasts longer and more profound |
|
DisAdv of blocks
|
• Lasts longer
• Greater chance of complication – Hematoma – Intravascular injection – Slightly lower success rate – Trismus – Anesthesia more wide spread than desired |
|
Blocks
|
ASA - canine to canine and anterior soft tissue
MSA - premolars, ant soft tissue, and ML cusp of 1st molar PSA - molars, ant soft tissue GP - hard palate through canines |
|
Bevel Towards Bone During
Injection |
less likely to penetrate
periosteum and cause pain and bruising |
|
PSA
|
• Anesthetizes
– Maxillary 3rd, 2nd, and 1st molars; (MB root of 1st molar not anesthetized = 28%) – Buccal periodontium and facial bone • Indications – Treating >1 maxillary molar – Infection in site – Infiltration not effective • Contraindication: risk of hemorrhage too great |
|
PSA adv
|
• Atraumatic
• 95% success rate • Less injections when treating multiple teeth • Less total volume |
|
PSA DisAdv
|
• Hematoma
• No bony landmarks • 2nd injection usually required for 1st molar |
|
Alternatives to PSA
|
PDL injections, infiltrations, V2
Block |
|
Infraorbital Nerve Block
|
• Anesthetrizes
– ASA nerve: pulps of incisors and canine – MSA nerve: 72% pulp of premolars, MB root of 1st – Infraorbital nerve • Inferior palpebral • Lateral nasal • Superior labial – Facial bone and periodontium of effected teeth • Indications – Multiple teeth – Infection – Infiltrations not effective • Contraindications – 1 or 2 teeth – Bleeding disorders, anticoagulants • Advantages – Simple – Minimal volume of solution – Minimal punctures • Disadvantages – Lack of confidence in operator – fear of injury to eye – Landmarks usually difficult to palpate |
|
Greater Palatine Nerve Block
|
• Anesthetizes posterior portion of hard palate
and its overlying soft tissues, anteriorly as far as the 1st premolar and medially to the midline. • Indications: pain control during restorative, periodontal, or oral surgical procedures • Contraindications – Inflammation in site – Smaller area of therapy (1 or 2 teeth) • Advantages – Minimizes needle penetrations and volume of solution – Minimizes patient discomfort – mucosa at site of injection not attached • Disadvantages – No hemostasis except at site of injection – Potentially traumatic/painful • Alternatives: infiltration, V2 block |
|
Nasopalatine Nerve Block
|
• Anesthetizes nasopalatine nerves bilaterally
anterior portion of hard palate (soft and hard tissues) from mesial of right 1st premolar to the mesial of the left 1st premolar • Indications: restorative, periodontal, or oral surgery procedures on multiple teeth • Contraindications – Inflammation or infection in area – Smaller area of therapy • Advantages – Fewer needle penetrations – Less volume of solution • Disadvantages – Hemostasis only in area of injection – Potentially the most painful intraoral injection • Alternatives – Local infiltrations – Maxillary nerve (V2) block |
|
Maxillary Nerve (V2) Block
|
• Contraindications
– Inexperienced operator – Pediatric patient – Uncooperative patient – Inflammation or infection at injection site – When hemorrhage is risky – Bony obstructions in canal (5-15%) • Anesthetizes – Pulpal anesthesia in hemimaxilla – Soft tissue and bone in hemimaxilla – Skin of lower eyelid, side of nose, cheek, upper lip • Indications – Extensive restorative, periodontal, or oral surgery procedures – Inflammation or infection precluding other blocks – Diagnosis or treatment of neuralias or tics of V2 nerve • Advantages – High success rate – 95% – Minimizes needle penetrations (1 vs 4) and volume of anesthetic (1 vs 2 carpules) – Usually atraumatic • Disadvantages – Risk of hematoma – Lack of hemostasis at surgery site – Discomfort – Arbitrary landmarks • Alternatives - other blocks, infiltrations |
|
V3 - Mandibular Division
of Trigeminal |
ANTERIOR
– Muscles of mastication • Temporalis • Masseter • Lateral pterygoid – Buccal nerve POSTERIOR – Auriculotemporal – Lingual – Inferior Alveolar • Mylohyoid |
|
Inferior Alveolar Nerve Block
|
• AKA mandibular nerve block
• Most commonly used • Highest rate of failure (15-20%) • Useful in quadrant dentistry • Try to avoid bilateral mandibular blocks (uncomfortable to the patient) • Most difficult block to master 1. Nerves Anesthetized -Inferior alveolar, mental, incisive, lingual (usually) 2. Indications -procedures on multiple teeth in one quadrant -buccal and lingual soft tissue required |
|
Inferior Alveolar Nerve Block
3. Contraindications |
-infection or acute inflammation
-tongue and lip biters (children, mentally handicapped) |
|
IANB 4. Advantages
|
-One injection provides a wide area of
anesthesia |
|
Inferior Alveolar Nerve Block
5. Disadvantages |
-sometimes not necessary for localized
areas/procedures -high block failure rate -intra-oral landmarks not consistent -high rate of positive aspiration (10-15%) -lingual and lip anesthesia (biters/hot beverages) |
|
Inferior Alveolar Nerve Block
Insertion/Target |
6. Insertion
-mucosa on medial aspect of the mandibular ramus 7. Target -Inferior alveolar nerve before it enters the foramen |
|
Inferior Alveolar Nerve Block
8. Landmarks |
-coronoid notch (greatest
concavity on the anterior border of the ramus) -pterygomandibular raphe -occlusal plane of the mandibular posterior teeth |
|
Inferior Alveolar Nerve Block
9. Failures |
-deposition of anesthetic below mandibular
foramen -deposition of anesthetic too far anteriorly -accessory innervation of the mandibular teeth (mylohoid nerve posteriorly and mylohoid/overlapping fibers of contralateral IAN) -bifid inferior alveolar nerve (lower) |
|
Inferior Alveolar Nerve Block
10. Complications |
-Hematoma (hold pressure)
-Trismus -Facial Paralysis (anesthetic in parotid) |
|
Inferior Alveolar Block
11. Technique |
-place index finger or thumb on the coronoid notch,
pull tissue tight -6 to 10mm above the occlusal plane of the mandible or the middle of finger thumb determines the height of injection -the anteroposterior point of the injection is then ¾ the distance to the pterygomandibular raphe -align the barrel of the syringe across the contralateral premolars – Height of injection • Coronoid notch • 6-10 mm above the occlusal plane – A-P site of injection • Into base of “V” formed by pterygomandibular raphe and ramus of mandible – Penetration depth • 20-25mm, 2/3 to ¾ the length of a long needle – Height of injection • Coronoid notch • 6-10 mm above the occlusal plane – A-P site of injection • Into base of “V” formed by pterygomandibular raphe and ramus of mandible – Penetration depth • 20-25mm, 2/3 to ¾ the length of a long needle |
|
Inferior Alveolar Block
12. Adjunctive Mylohyoid Block |
-retract tongue to midline, then inject at
the apical area of second molar on the lingual surface of the mandible |
|
IANB - 13. Adjunctive Contralateral Inferior Alveolar
|
-supraperiosteal injection technique
across the midline of the anterior mandibular teeth (buccal surface) |
|
IANB Adjunctive Lingual Nerve Block
|
-deposit 0.1 to 0.2 ml of anesthetic when
withdrawing needle from inferior alveolar block |
|
Inferior Alveolar Block
15. Signs and Symptoms |
-tingling or numbness of lip
and chin to midline -tingling or numbness of the ipsilateral anterior two thirds of the tongue -anesthesia of teeth and gingiva ipsilaterally (except buccal nerve distribution) |
|
Buccal Nerve Block
|
• AKA long buccal nerve block
• Anesthetizes soft tissues and periosteum buccal to the mandibular molars 1. Indications -buccal soft tissue anesthesia for procedures on the mandibular molars 2. Contraindications -infection/inflammation in the area |
|
Adv/DisAdv of Long Buccal Block
|
3. Advantages
-easy, high success rate 4. Disadvantages -potentially painful if periosteum is torn |
|
Long buccal insertion/target
|
5. Insertion
-mucosa distal and buccal to the most posterior mandibular molar 6. Target -buccal nerve as it passes over the anterior border of the ramus 7. Landmarks -mandibular molars -mucobuccal fold 8. Failures -rare |
|
Long Buccal complications and technique
|
9. Complications
-rare (hematoma) 10. Technique -penetrate mucosa about 2mm contact bone -aspirate and inject |
|
Gow-Gates Block
|
• AKA mandibular block
• Blocks entire distribution of V3 • Anesthesia of inferior alveolar, lingual, mental, incisive, mylohoid, buccal and auriculotemporal nerves • Difficult learning curve • More successful than inferior alveolar block |
|
Gow-Gates Block
1. Indications |
1. Indications
-procedures on multiple teeth -soft tissue anesthesia -failed inferior alveolar block 2. Contraindications -infection/inflammation -lip/tongue biters -patients who are unable to open mouth wide |
|
Gow-Gates Block
3. Advantages |
-only one injection
-high success rate (95%) -minimal complications -successful anesthesia of bifid inferior alveolar nerves |
|
Gow-Gates Block
4. Disadvantages |
-tongue/lip anesthesia
-longer time to onset of anesthesia -high learning curve |
|
Gow Gates insertion/target
|
5. Insertion
-mucosa on the mesial of ramus in line of tragus and commissure distal to the maxillary second molar 6. Target -lateral surface of condylar neck, below insertion of lateral pterygoid 7. Landmarks -tragus and commissure -just below the mesiopalatal cusp of the maxillary second molar |
|
Gow-Gates Block
8. Failures |
-Insufficient volume of anesthetic (bigger
nerve) -anatomical difficulties (do not deposit anesthetic unless bone is contacted) |
|
Gow-Gates Block
9. Complications |
-hematoma (rare)
-trismus (rare) -paralysis of cranial nerve III, IV, VI (eye paralysis, diplopia) |
|
Gow-Gates Block
10. Technique |
-have patient open wide, point of
insertion below mesiopalatal cusp of maxillary second molar aiming to tragus of ear (considerably higher than occlusal plane) -advance needle 20-25mm until bone is contacted aspirate and inject -have patient stay open 1-2 minutes after injection |
|
Akinosi Block
|
• AKA closed mouth block
• Useful when dental therapy required in patients with limited mouth opening (trismus) 1. Indications -limited mouth opening -inability to visualize landmarks for conventional block |
|
Akinosi Block
2. Contraindications |
-infection or acute inflammation
-lip/tongue biters -inability to gain access to the lingual aspect of ramus |
|
Akinosi Block Adv/DisAdv
|
3. Advantages
-no mouth opening required -works on patients with bifid inferior alveolar nerves -lower aspiration rate/atraumatic 4. Disadvantages -difficult to visualize path of needle and depth of insertion -no bone contact |
|
Akinosi insertion/target
|
5. Insertion
-soft tissue overlying medial border of ramus adjacent to maxillary tuberosity at the mucogingival junction height 6. Target -soft tissue of the medial ramus (below Gow-gates and above Inferior alveolar block) 7. Landmarks -mucogingival junction of maxillary (second/third molar) -maxillary tuberosity/ coronoid notch |
|
Akinosi Block
8. Failures and complications |
8. Failures
-must stay in line with flare of the mandible or injection will be too lateral -needle insertion too low -under/overinsertion of the needle 9. Complications -Hematoma/trismus -facial nerve paralysis (overinsertion into parotid gland) |
|
Akinosi Block
10. Technique |
-bevel of needle away from bone
-advance needle 25mm -aspirate -inject |
|
Mental/Incisive
Block |
• The mental nerve leaves the mental
foramen and provides sensory innervation to the lip and chin area • The incisive nerve continues forward to provide sensory innervation to the anterior mandibular teeth • Both have limited usefulness on a routine basis for dental therapy |
|
Mental Block indications/counterindications
|
1. Indications
-buccal soft tissue anesthesia for procedures anterior to the mental foramen (biopsy) 2. Contraindications -inflammation and infection in the areas |
|
Mental block adv/disadv
|
3. Advantages
-high success rate -easy/atraumatic 4. Disadvantages -hematoma (5%) |
|
Mental block insertion/target
|
. Insertion
-mucobuccal fold anterior to foramen 6. Target -mental nerve as it exits the mental foramen 7. Landmarks -mandibular premolars -mucobuccal fold |
|
Mental block failures / complications
|
-rare
-miss the foramen 9. Complications -hematoma |
|
Mental block technique
|
10. Technique
-locate foramen with finger in mucobuccal fold -insert needle anterior to foramen (5mm) -aspirate and inject |
|
Incisive block indications/contraindications
|
1. Indications
-dental procedures which require pulpal anesthesia of the mandibular anterior teeth -used instead of bilateral inferior alveolar blocks for treatment limited to the anterior mandible 2. Contraindications -inflammation or infection |
|
Incisive Nerve block adv/disadv
|
3. Advantages
-pulpal anesthesia of the anterior mandibular teeth without lingual anesthesia (uncomfortable) -high success rate 4. Disadvantages -no lingual anesthesia -cross innervation from contralateral inferior alveolar nerve may require additional supraperiosteal injections for pulpal anesthesia |
|
Incisive Nerve Block
5. Insertion, target, landmarks |
5. Insertion
-mucobuccal fold anterior to mucobuccal fold 6. Target -mental foramen (incisive nerve lies in this) 7. Landmarks -mandibular premolars -mucobuccal fold |
|
Incisive Nerve Block
8. Failure/complications |
8. Failure
-Inadequate volume of anesthetic -Inadequate pressure after injection 9. Complications -rare -hematoma |
|
Incisive Nerve Block
10. Technique |
10. Technique
-same as for mental block -hold pressure for two minutes after injection to force anesthetic into the foramen and reach the incisive nerve |
|
Mandibular Infiltration
|
• Useful for supplemental anesthesia of anterior
mandibular teeth when getting crossover fibers from contralateral inferior alveolar nerve • Thin cortical plate allows for supraperiosteal injection technique to be successful for mandibular incisors only in most patients • Technique exactly the same as for maxillary teeth with deposition of anesthetic at root apex to block dental plexus |
|
Injection Pearls
|
• Always recap needle after injection
• Be confident • Understand the anatomy • Always aspirate • Always use a finger rest for stabilization • If the patient complains of an electric shock after the needle is positioned, reposition the needle as you are likely in the nerve itself |